Paul Tudor Jones Arvinas, Inc. Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Arvinas, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 37,505 shares of ARVN stock, worth $917,372. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37,505Holding current value
$917,372% of portfolio
0.01%Shares
8 transactions
Others Institutions Holding ARVN
# of Institutions
234Shares Held
64.9MCall Options Held
119KPut Options Held
94.2K-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$165 Million7.92% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.3MShares$154 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$134 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.37MShares$107 Million0.02% of portfolio
-
Rtw Investments, LP New York, NY3.3MShares$80.7 Million2.18% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.3B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...